---
created: '2026-02-08T19:45:44.517064Z'
description: A lysine salt of ibuprofen used for rapid pain relief and specifically
  for the closure of patent ductus arteriosus in premature infants.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/drug/ibuprofen-lysine/
slug: ibuprofen-lysine
tags:
- drug
- nsaid
- pediatric
- fast-acting
title: Ibuprofen Lysine
type: drug
updated: '2026-02-08T19:45:44.517064Z'
---

# Ibuprofen Lysine

## Overview

Ibuprofen Lysine (NeoProfen) is a highly soluble form of ibuprofen. While used orally for fast pain relief, its most critical clinical application is intravenous use in the neonatal intensive care unit (NICU) to treat **Patent Ductus Arteriosus (PDA)**.

## Indications

- **Patent Ductus Arteriosus (PDA):** In premature infants.
- **Acute Pain.**
- **Migraine.**

<!-- NEO4J_CONTENT_START -->
## Relationships
No relationships found.
<!-- NEO4J_CONTENT_END -->
## Relationships

TREATS_CONDITION::[[Patent Ductus Arteriosus]]
TREATS_CONDITION::[[Pain]]
ASSOCIATED_WITH_CONDITION::[[Premature Birth]]
INHIBITS_PROTEIN::[[COX-1]]
INHIBITS_PROTEIN::[[COX-2]]
DRUG_CONTAINS_COMPOUND::[[Ibuprofen]]

## References

- FDA. NeoProfen (Ibuprofen Lysine) Injection.
- Ohlsson, A., et al. (2017). Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews.
- MedlinePlus. Ibuprofen Lysine.